profileflipping

150 results found.

Top Stocks matching your search for "profile flipping"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
VLON

Vallon Pharmaceuticals Inc

49.05%

$0.28 - $0.41

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
COSM

Cosmos Holdings Inc

-39.30%

$5.00 - $3.04

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Dec, 16, 2022

I just love watching my profiles fly out the window..

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 6, 2023

Blood thinner Eliquis captured significant market ... See more

Jan, 4, 2023

$TGTX paid troll for Goldman or BOA, superb labeli... See more

VLON

Vallon Pharmaceuticals Inc

49.05%

$0.28 - $0.41

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.

COSM

Cosmos Holdings Inc

-39.30%

$5.00 - $3.04

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Dec, 16, 2022

I just love watching my profiles fly out the window..

TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 6, 2023

Blood thinner Eliquis captured significant market from Xarelto due to its safety profile.

Jan, 4, 2023

$TGTX paid troll for Goldman or BOA, superb labeling with excellent safety profile and no warning

Jan, 4, 2023

Imagine how much Ubli could be worth to BP now with Briumvi’s best in class product profile.

Dec, 30, 2022

Clear best in class profile, less of a burdensome for pts, less time at care centers and less expensive for providers.